TAGRAXOFUSP

538 reported adverse events

Drug classes: CD123 Interaction [EPC] Cytotoxin [EPC]

These side effects are most commonly reported by patients taking TAGRAXOFUSP:

# Side effect Count
0 CAPILLARY LEAK SYNDROME 130
1 PYREXIA 47
2 OFF LABEL USE 43
3 DEATH 41
4 DISEASE PROGRESSION 38
5 THROMBOCYTOPENIA 35
6 BLOOD ALBUMIN DECREASED 29
7 DRUG INEFFECTIVE 28
8 WEIGHT INCREASED 28
9 TUMOUR LYSIS SYNDROME 27
See all common reactions for TAGRAXOFUSP

TAGRAXOFUSP is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANGIOGENESIS BIOMARKER DECREASED 4 0.6667
1 CAPILLARY PERMEABILITY 1 0.2000
2 RED BLOOD CELL ACANTHOCYTES PRESENT 3 0.1500
3 BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASIA 10 0.1235
4 TROPONIN I 1 0.0667
5 CAPILLARY LEAK SYNDROME 130 0.0628
6 ROULEAUX FORMATION 3 0.0517
7 CSF LACTATE INCREASED 1 0.0333
8 CAPILLARY PERMEABILITY INCREASED 2 0.0308
9 ORBITAL SWELLING 1 0.0172
See all enriched reactions for TAGRAXOFUSP